| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |